February 26, 2020 / 1:08 PM / 3 months ago

BRIEF-Translate Bio Receives FDA Fast Track Designation For MRT5005 For The Treatment Of Cystic Fibrosis

Feb 26 (Reuters) - Translate Bio Inc:

* TRANSLATE BIO RECEIVES FDA FAST TRACK DESIGNATION FOR MRT5005 FOR THE TREATMENT OF CYSTIC FIBROSIS

* TRANSLATE BIO - 1ST INHALED MRNA THERAPEUTIC ON TRACK TO REPORT RESULTS FROM MULTIPLE-ASCENDING DOSE PORTION OF PHASE 1/2 CLINICAL TRIAL IN Q3 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below